Fraser Bocell

Company: Critical Path Institute (C-Path)
Job title: Senior Clinical Outcomes Assessment Scientist
Seminars:
Presenter Q+A & Audience Discussion 12:30 pm
day: Conference Day Two - Track Three
Unpacking FDA’s Response to the Alpha-Synuclein Seed Amplification Assay: What Does This Mean for the Future of Parkinson’s Clinical Trials? 12:00 pm
Showcasing the latest advancements of αSyn-SAA in monitoring drug-induced improvement in PD progression Highlighting opportunities unlocked by αSyn-SAA to establish objective endpoints and monitor efficacy of PD drugsRead more
day: Conference Day Two - Track Three
Panel Discussion: Exploring Opportunities in Alpha-Synuclein & Beyond for More Transformative & Efficacious Therapies: What’s Coming Next in Parkinson’s Drug Development? 4:30 pm
Overview of trehalose and its effects as a modulator of autophagy Pharmacokinetics and brain penetration of trehalose in rodents and non-human primates Lowering the therapeutic dose of trehalose and moving into clinical developmentRead more
day: Conference Day One PM